HomeCompareSUMO vs MRK

SUMO vs MRK: Dividend Comparison 2026

SUMO yields 16.61% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SUMO wins by $2.4K in total portfolio value
10 years
SUMO
SUMO
● Live price
16.61%
Share price
$12.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$59.2K
Annual income
$4,608.53
Full SUMO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SUMO vs MRK

📍 SUMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSUMOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SUMO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SUMO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SUMO
Annual income on $10K today (after 15% tax)
$1,411.96/yr
After 10yr DRIP, annual income (after tax)
$3,917.25/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $4,411.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SUMO + MRK for your $10,000?

SUMO: 50%MRK: 50%
100% MRK50/50100% SUMO
Portfolio after 10yr
$58.0K
Annual income
$7,203.34/yr
Blended yield
12.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SUMO
Analyst Ratings
1
Buy
7
Hold
Consensus: Hold
Price Target
$10.00
-16.9% upside vs current
Range: $10.00 — $10.00
Altman Z
3.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SUMO buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSUMOMRK
Forward yield16.61%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$59.2K$56.8K
Annual income after 10y$4,608.53$9,798.13
Total dividends collected$30.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$10.00$128.54

Year-by-year: SUMO vs MRK ($10,000, DRIP)

YearSUMO PortfolioSUMO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,361$1,661.13$11,206$366.19+$1.2KSUMO
2$15,145$1,919.01$12,650$502.35+$2.5KSUMO
3$18,403$2,197.44$14,407$694.19+$4.0KSUMO
4$22,187$2,495.41$16,585$967.82+$5.6KSUMO
5$26,551$2,811.64$19,342$1,363.89+$7.2KSUMO
6$31,555$3,144.65$22,913$1,947.19+$8.6KSUMO
7$37,256$3,492.72$27,662$2,823.89+$9.6KSUMO
8$43,718$3,854.03$34,159$4,173.35+$9.6KSUMO
9$51,005$4,226.64$43,337$6,308.80+$7.7KSUMO
10$59,184$4,608.53$56,776$9,798.13+$2.4KSUMO

SUMO vs MRK: Complete Analysis 2026

SUMOStock

Sumo Logic, Inc. provides cloud-native software-as-a-service platform that enables organizations to address the challenges and opportunities presented by digital transformation, modern applications, and cloud computing worldwide. It offers Continuous Intelligence Platform, a cloud-native, multi-tenant, and secure service that leverages to enable reliability and security of cloud applications and workloads. The company also provides observability solution, an out-of-the-box solution for managing their application reliability for cloud applications; and security solution that helps developers, security analysts, and security operation centers that detect threats, perform security analysis and forensics, and automate security responses to remediate against those threats for cloud applications. The company was incorporated in 2010 and is headquartered in Redwood City, California.

Full SUMO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SUMO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SUMO vs SCHDSUMO vs JEPISUMO vs OSUMO vs KOSUMO vs MAINSUMO vs JNJSUMO vs ABBVSUMO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.